Metro (TSE:MRU – Get Free Report) received a C$98.00 target price from equities research analysts at UBS Group in a research report issued to clients and investors on Friday,BayStreet.CA reports. The brokerage currently has a “neutral” rating on the stock. UBS Group’s price objective would indicate a potential upside of 5.31% from the company’s current price.
Several other equities research analysts have also issued reports on the company. Royal Bank of Canada lowered Metro from a “moderate buy” rating to a “hold” rating in a research note on Thursday, November 21st. Desjardins lifted their price objective on shares of Metro from C$85.00 to C$95.00 in a research note on Friday, November 22nd. Cfra increased their target price on shares of Metro from C$76.00 to C$85.00 in a research note on Thursday, August 15th. BMO Capital Markets lifted their price target on shares of Metro from C$82.00 to C$85.00 in a research note on Thursday, August 15th. Finally, CIBC increased their price objective on shares of Metro from C$86.00 to C$91.00 in a research report on Thursday, November 21st. Seven equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat, Metro currently has a consensus rating of “Hold” and a consensus price target of C$88.67.
View Our Latest Report on Metro
Metro Stock Performance
About Metro
Metro Inc, through its subsidiaries, operates as a retailer, franchisor, distributor, and manufacturer in the food and pharmaceutical sectors in Canada. The company operates supermarkets, discount, neighborhood, and specialty stores that provide fresh and grocery products, baked goods, prepared food products, meats, dairy products, fruits and vegetables, frozen food products, bakery products, delicatessen items, and pastries.
See Also
- Five stocks we like better than Metro
- CD Calculator: Certificate of Deposit Calculator
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What is Insider Trading? What You Can Learn from Insider Trading
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Metro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metro and related companies with MarketBeat.com's FREE daily email newsletter.